ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms

Stock Information for ImmunoPrecise Antibodies Ltd.

Loading

Please wait while we load your information from QuoteMedia.